{"data":[{"accessionNo":"0000935836-26-000405","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001385818","issuerName":"AYTU BIOPHARMA, INC","ticker":"AYTU","cusip":"054754858","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"LYTTON-KAMBARA FOUNDATION","reportingCik":null,"personType":"IN","sharesOwned":545946,"percentOfClass":4.99,"filedAt":"2026-08-14"},{"accessionNo":"0000935836-26-000405","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001385818","issuerName":"AYTU BIOPHARMA, INC","ticker":"AYTU","cusip":"054754858","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"LYTTON LAURENCE W","reportingCik":null,"personType":"IN","sharesOwned":545946,"percentOfClass":4.99,"filedAt":"2026-08-14"},{"accessionNo":"0000935836-26-000109","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001385818","issuerName":"AYTU BIOPHARMA, INC","ticker":"AYTU","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"LYTTON LAURENCE W","reportingCik":null,"personType":"IN","sharesOwned":1071351,"percentOfClass":9.99,"filedAt":"2026-02-17"},{"accessionNo":"0000935836-26-000109","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001385818","issuerName":"AYTU BIOPHARMA, INC","ticker":"AYTU","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"LYTTON-KAMBARA FOUNDATION","reportingCik":null,"personType":"IN","sharesOwned":895528,"percentOfClass":8.8,"filedAt":"2026-02-17"},{"accessionNo":"0001535264-26-000010","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001385818","issuerName":"AYTU BIOPHARMA, INC","ticker":"AYTU","cusip":null,"securityClass":"Common Stock, Par Value $0.0001","eventDate":"2025-12-31","reportingPerson":"AWM Investment Company, Inc.","reportingCik":null,"personType":"IA","sharesOwned":619574,"percentOfClass":5.8,"filedAt":"2026-02-13"},{"accessionNo":"0000935836-25-000682","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001385818","issuerName":"AYTU BIOPHARMA, INC","ticker":"AYTU","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"LYTTON LAURENCE W","reportingCik":null,"personType":"IN","sharesOwned":1086522,"percentOfClass":9.99,"filedAt":"2025-11-14"},{"accessionNo":"0000935836-25-000682","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001385818","issuerName":"AYTU BIOPHARMA, INC","ticker":"AYTU","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"Lytton-Kambara Foundation","reportingCik":null,"personType":"IN","sharesOwned":1086522,"percentOfClass":9.99,"filedAt":"2025-11-14"},{"accessionNo":"0001193805-25-001566","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001385818","issuerName":"AYTU BIOPHARMA, INC","ticker":"AYTU","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Kanen Wealth Management LLC","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-12"},{"accessionNo":"0001193805-25-001566","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001385818","issuerName":"AYTU BIOPHARMA, INC","ticker":"AYTU","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Kanen David","reportingCik":null,"personType":"IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-12"},{"accessionNo":"0001193805-25-001566","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001385818","issuerName":"AYTU BIOPHARMA, INC","ticker":"AYTU","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Philotimo Focused Growth & Income Fund","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-12"},{"accessionNo":"0001193805-25-001566","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001385818","issuerName":"AYTU BIOPHARMA, INC","ticker":"AYTU","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Philotimo Fund, LP","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-11-12"}],"updatedAt":"2026-09-19T01:17:27.197Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data"}